Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

J&J’s Janssen Loses $11 Million Jury Verdict Over Topamax
Bloomberg
Tuesday, November 19, 2013 - 7:38am
tags:
Janssen, JNJ, Topamax, birth defects
FDA approving drugs faster, and it may stay that way, report says
Marketwatch
Tuesday, November 19, 2013 - 7:37am
tags:
FDA, drug approvals
Gilead's HIV-1 Drug Wins Approval in Europe
Motley Fool
Tuesday, November 19, 2013 - 7:37am
tags:
HIV-1, Gilead Sciences, Vitekta, Europe
Don't Crown the Hepatitis C Drug Winner Just Yet
Motley Fool
Tuesday, November 19, 2013 - 7:35am
tags:
hepatitis C, Gilead Sciences, ABT-333, Ribavirin, ABT-450, ritonavir, ABT-267, AbbVie
Aegerion reports results from Phase 3 study of Juxtapid
Yahoo/Fly on the Wall
Tuesday, November 19, 2013 - 7:27am
tags:
Aegerion, Juxtapid, Homozygous Familial Hypercholesterolemia
Celgene's Revlimid Faces a Tough Sell
Motley Fool
Tuesday, November 19, 2013 - 7:25am
tags:
Celgene, Revlimid, JNJ, Multiple Myeloma
Biogen Idec 5-Year Revenue Outlook
Seeking Alpha
Tuesday, November 19, 2013 - 7:24am
tags:
Biogen Idec
US Senate Passes Compounding And Track-And-Trace Bill
Pharmalot
Monday, November 18, 2013 - 5:08pm
tags:
compounding pharmacies, track and trace bill
Amgen presents survival data from Phase 3 study of talimogene laherparepvec
Yahoo/Fly on the Wall
Monday, November 18, 2013 - 4:39pm
tags:
Amgen, Talimogene Laherparepvec, melanoma
Pfizer's Oncology Segment Comes To Its Rescue
Seeking Alpha
Monday, November 18, 2013 - 4:37pm
tags:
undefined
Johnson & Johnson’s Imbruvica Will Be a Costly Treatment
Wall St Cheat Sheet
Monday, November 18, 2013 - 4:36pm
tags:
JNJ, Imbruvica, mantle cell lymphoma, Pharmacyclics
Cholesterol Guidelines Move Forward as Risk Tool Debated
Bloomberg
Monday, November 18, 2013 - 4:34pm
tags:
cholesterol, statins
Merck Scores in Investigational Melanoma Study Results
Yahoo/Wall St 24-7
Monday, November 18, 2013 - 4:33pm
tags:
Merck, melanoma, MK-3475
Takeda's new outsider CFO charged with $1B cost-cutting plan
Fierce Pharma
Monday, November 18, 2013 - 11:49am
tags:
Takeda
Pradaxa antidote works fast, completely in small trial
Reuters
Monday, November 18, 2013 - 11:48am
tags:
bloodthinners, Pradaxa, Boehringer Ingelheim
By The Numbers? Flawed Cholesterol Calculator May Boost Statins
Pharmalot
Monday, November 18, 2013 - 11:47am
tags:
cholesterol, statins
Titan Pharma Gets Solidified Commitment From Braeburn To Probuphine
Seeking Alpha
Monday, November 18, 2013 - 11:29am
tags:
Titan Pharmaceuticals, Braeburn Pharmaceuticals, Probuphine
TriVascular raises $40M Series E round
Mass Device
Monday, November 18, 2013 - 11:24am
tags:
TriVascular, devices, Ovation, stent grafts
Has Myeloma Met Its Match in Amgen's Kyprolis?
Motley Fool
Monday, November 18, 2013 - 11:07am
tags:
Multiple Myeloma, Amgen, Kyprolis, Celgene
Gilead’s Idelalisib Significantly Reduces Rate of Disease Progression or Death in Phase 3 Chronic Lymphocytic Leukemia Study
Yahoo
Monday, November 18, 2013 - 10:28am
tags:
Gilead, Idelalisib, CLL, chronic lymphocytic leukemia

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.